Carregant...
Fitxers
Tipus de document
Part del llibreVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/178773
Neuroprotection: A New Therapeutic Approach of Relapsing Remitting Multiple Sclerosis
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Neurodegenerative changes occurring early from primary acute immune-mediated
inflammation support the hypothesis that multiple sclerosis (MS) is a complex disease.
Axonal loss progresses with the disease course and represents the principal driver of
disability. In this context, the pursuit of neuroprotective therapies in multiple sclerosis
provides new valid alternatives that could significantly impact on disease progression
and neurodegenerative changes, including the promotion of restoration of myelin
sheaths through the remyelination process. This chapter reviews promising drugs with
proposed neuroprotective or neuroregenerative effects that are currently approved or
in clinical trials for the treatment of multiple sclerosis. Although the chapter highlights
the diazoxide action on neuroinflammation and the results of a clinical trial with
this drug, the review also includes other molecules with oral or parenteral administration.
Matèries
Matèries (anglès)
Citació
Col·leccions
Citació
ESPINOSA PARRILLA, Juan francisco, PUGLIESE, Marco, MAHY GEHENNE, Josette nicole, RODRÍGUEZ ALLUÉ, Manuel josé. Neuroprotection: A New Therapeutic Approach of Relapsing Remitting Multiple Sclerosis. _Chapter 13 in: Gonzalez-Quevedo_. Alina. 2016. Trending Topics in Multiple Sclerosis. IntechOpen. ISBN: 978-953-51-7310-6. DOI: 10.5772/61417. pp: 307-328.. [consulta: 21 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/178773]